Melflufen in patients (pts) with relapsed/refractory multiple myeloma (RRMM) refractory to daratumumab (dara) and/or pomalidomide (pom) (OP-106) Meeting Abstract
| Authors: | Richardson, P. G.; Oriol, A.; Larocca, A.; Otero, P. R.; Moreb, J.; Blade, J.; Hassoun, H.; Cavo, M.; Alegre, A.; Mazumder, A.; Maisel, C.; Paner, A.; Leleu, X.; Zonder, J. A.; Harmenberg, J.; Thuresson, S.; Zubair, H.; Mateos, M. V. |
| Abstract Title: | Melflufen in patients (pts) with relapsed/refractory multiple myeloma (RRMM) refractory to daratumumab (dara) and/or pomalidomide (pom) (OP-106) |
| Meeting Title: | 110th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2019 Mar 29-Apr 3 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-07-01 |
| Language: | English |
| ACCESSION: | WOS:000488129900138 |
| DOI: | 10.1158/1538-7445.Am2019-ct154 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT154 -- Source: Wos |
